Ceftriaxone & tazobactum

Additional Details

Ceftrabact inj. (Ceftriaxone 1000 mg. + Tazobactum 125 mg.) A Defense against Deadly attack is.

• A resistant- protected ceftriaxone with retained antibacterial spectrum
• Possesses a long elimination half-life permitting once-daily administration
• Ensures feasible out-patient therapy unlike other parenteral cephalosporins
• Also indicated in nosocomial infections with or without an aminoglycoside in serious Gram-negative infectio, pneumonia, sepontaneous bcterial peritonitis and as surgical prophylaxis
•  Commendable effect in I.C.U. Patients
• Respiratory Tract Infection
• Pneumonia
• Mixed bacterial Infections
• Noscomial Infections
• In Ventilator-associated pneumonia
• Helpful companion of amino-glyvoside antibiotics